The Psychedelic History Archive

Rajesh Narendran

Browse filters
Active filters:Person: Rajesh Narendran xClear all
Psychopharmacologic Drugs Advisory Committee Meeting on Midomafetamine (MDMA) for PTSD: Discussion and Votes
FDA advisory committee on MDMA, 2024